Search the Newsreel

Veradermics (NYSE: MANE) posts larger loss as cash surges above $800M

Veradermics (NYSE: MANE) reported a significantly larger net loss of $50.7 million for the first half of 2026, compared to $28.0 million in the prior year, primarily due to increased operating expenses in research and development and general and administrative costs. Despite the losses, …

Fund Update: 153,098 MONSTER BEVERAGE (MNST) shares added to Vanguard Personalized Indexing Management, LLC portfolio

Vanguard Personalized Indexing Management, LLC has added 153,098 shares of MONSTER BEVERAGE (MNST) to their portfolio, as disclosed in a recent SEC 13F filing for the 06-30-2026 report period. This update highlights significant institutional investor activity in MNST, with 700 institutions increasing and 546 …

Monster Beverage Corp Stock (MNST) Moved Down by 49.76% on Aug 11: Key Drivers Unveiled

Monster Beverage Corp (MNST) stock experienced a significant drop of 49.76% on August 11, primarily due to a two-for-one stock split that recalibrated its nominal share price without altering its market capitalization or fundamental value. Despite the technical price adjustment, the company reported strong …

MNST Q2 Deep Dive: International Acceleration, Margin Compression, and Innovation Drive Focus

MNST Q2 Deep Dive: International Acceleration, Margin Compression, and Innovation Drive Focus Energy drink company Monster Beverage (NASDAQ:MNST) announced better-than-expected revenue in Q2 CY2026, with sales up 20.2% year on year to $2.54 billion. Its non-GAAP profit of $0.59 per share was in line …

Veracyte at canaccord growth conference: growth balanced with margins

Veracyte (VCYT) outlined a strategy for growth balanced with disciplined spending at Canaccord Genuity’s 46th Annual Growth Conference. The company raised its full-year 2024 revenue guidance to $600 million after strong Q2 results, achieving over 29% adjusted EBITDA margin and over $40 million in …

D.A. Davidson reiterates Neutral rating on LiveRamp stock

D.A. Davidson reiterated a Neutral rating and $38.50 price target for LiveRamp Holdings Inc. after the company reported a slight revenue beat and better-than-expected profitability. LiveRamp is set to be acquired by Publicis by the end of 2026, which led to the company not …

Veradermics reports Q2 2026 net loss $23.5M; cash $819.9M funds operations into 2030

Veradermics reported a net loss of $23.5 million for Q2 2026, an increase from $15.6 million in Q2 2025, driven by higher R&D and G&A expenses. Despite the loss, the company holds a strong cash position of $819.9 million, expected to fund operations into …

Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Veradermics announced positive second-quarter 2026 financial results and significant clinical progress for its lead drug candidate, VDPHL01, an extended-release oral minoxidil for pattern hair loss. The company reported positive Phase 2 results for female pattern hair loss, completed enrollment for a pivotal Phase 2/3 …

Por que as ações da Monster Beverage estão subindo hoje? - Investing.com Brasil

VSTM Maintains by Mizuho -- Price Target Lowered to $13.00

Mizuho maintained an "Outperform" rating for Verastem (VSTM) but lowered its price target from $14.00 to $13.00, reflecting market sentiment and challenges despite the company's focus on novel anticancer agents. Verastem's GF Score™ of 14/100 highlights significant financial and profitability struggles, with insider activity …

MNST Looks 16.0% Overvalued on GF Value™ as Market Reacts to Q2 EPS

Monster Beverage Corp (MNST) shares declined by 6% last week following its Q2 EPS announcement, despite Morgan Stanley viewing the market reaction as overly negative. GuruFocus's GF Value™ indicates the stock is 16.0% overvalued, trading at $45.72 against an intrinsic value of $39.41, and …

Earnings Flash (MANE) Veradermics Posts Q2 Net Loss $23.5M, vs. FactSet Est of $26.8M Loss

Mizuho lowers Verastem stock price target on valuation to $13

Mizuho has lowered its price target for Verastem Inc. (NASDAQ:VSTM) to $13 from $14, while maintaining an Outperform rating, following strong Q2 2026 results that surpassed analyst expectations. The company reported significant revenue growth, a high gross profit margin, and secured new financing, extending …

Molson Coors Beverage Company $TAP Shares Sold by Sage Capital Advisors llc

Form 8K Liveramp Holdings Inc For: 10 August By Investing.com

The article reports that LiveRamp Holdings Inc. filed a Form 8K on August 10th. This filing is a significant event for public companies, often indicating important news or changes. The brief article, published by Investing.com, simply notes the occurrence of this filing.

Eastroc Beverage Sets August 2026 Cut-Off for H-Shareholders Ahead of Extraordinary Meeting

Sei Investments Co. Decreases Position in LiveRamp Holdings, Inc. $RAMP

Sei Investments Co. reduced its stake in LiveRamp Holdings, Inc. (NYSE:RAMP) by 40.3% in the first quarter, selling 39,128 shares and retaining 57,962 shares valued at approximately $1.54 million

Veraxa Biotech AG Ord Shs (VRXA) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Veraxa Biotech AG Ord Shs (VRXA), detailing its future EPS and Revenue Growth Estimates. It includes current stock performance data, market capitalization, and a peer comparison with other biotechnology and medical research companies. The financial forecasting sections …

Ação da Monster Beverage atinge mínima de 52 semanas a US$ 45,72 - Investing.com Brasil

Monster Beverage stock hits 52-week low at $45.72 By Investing.com

Monster Beverage's stock has hit a 52-week low at $45.72, despite a 42.79% increase over the past year. InvestingPro's Fair Value analysis suggests the company is currently undervalued, showcasing strong fundamentals with gross profit margins of 55.6% and great financial health. The company recently …

Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating

Mizuho Securities has lowered its price target for Verastem (VSTM) to $13 from $14, while maintaining an Outperform rating on the stock. According to analysts, Verastem currently holds an average "buy" rating with a mean price target of $14.75. Access to the full MT …

Why Monster Beverage (MNST) Is Back In The Spotlight

Veradermics (MANE) Q1 2026 Earnings: Wider-than-Expected Loss Triggers Stock Decline - Strong Earnings Momentum

Vintage Coffee and Beverages Publishes Q1 FY27 Earnings Call Transcript

Vera Therapeutics (NASDAQ:VERA) Announces Quarterly Earnings Results

Vera Therapeutics (VERA) ramps spending ahead of TRUTAKNA launch and posts $230.5M loss

Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

Vera Therapeutics TRUTAKNA™ granted accelerated approval by U.S. Food and Drug Administration (FDA) in adult patients with primary IgA nephropathy (IgAN) at risk for disease progression. Alignment with FDA on earlier ORIGIN 3 final efficacy analysis to support potential full approval for TRUTAKNA in …

JPMorgan Chase & Co. Increases Molson Coors Beverage (NYSE:TAP) Price Target to $42.00

Veralto Corp. stock falls Monday, underperforms market

Veralto Corp. (VLTO) shares fell 1.25% on Monday, closing at $97.11. This underperformance occurred during a generally poor trading session for the broader market, with both the S&P 500 and Dow Jones Industrial Average also declining. The stock's drop ended a five-day winning streak.

Is Monster Beverage’s Best-Case Scenario Already Priced Into the Stock?

Monster Beverage (NASDAQ: MNST) exceeded Q2 earnings and revenue expectations, with net sales climbing over 20% year-over-year, and is implementing a 2-for-1 stock split on August 10th. While the company's fundamentals appear strong, its high P/E ratio above 40x suggests that much of this …

LiveRamp announces special shareholder meeting on merger proposal

LiveRamp will hold a virtual special stockholder meeting on August 17, 2026, where shareholders will vote on a proposed merger. Under this proposal, MMS USA Holdings would acquire LiveRamp through a merger subsidiary. This news brief was generated by Public Technologies (PUBT) using AI …

LiveRamp Files Supplemental Merger Proxy Disclosures Amid Stockholder Lawsuits

LiveRamp Holdings, Inc. filed supplemental disclosures to its definitive proxy statement on August 10, 2026, regarding its pending acquisition by MMS USA Holdings, Inc., an affiliate of Publicis Groupe S.A. This filing comes amid stockholder lawsuits related to the acquisition. The article provides this …

LiveRamp supplements proxy, discloses management retention talks, analyst targets and projections vs. $38.50 merger price

LiveRamp has released a supplement to its definitive proxy statement, revealing ongoing management retention discussions with Publicis, Evercore's valuation ranges, and standalone financial projections. The disclosures come amidst three stockholder lawsuits and multiple demand letters alleging proxy deficiencies, which LiveRamp denies but addressed to …

LiveRamp (NYSE: RAMP) expands Publicis merger analysis with $38.50 per share terms

LiveRamp Holdings, Inc. has provided additional details regarding its pending acquisition by Publicis Groupe S.A. for $38.50 per share in cash. The company expanded on the background of the merger, including efforts to retain key management and Evercore’s valuation analyses (discounted cash flow, trading, …

Investing in Monster Beverage (MNST)? Don't Miss Assessing Its International Revenue Trends

Have you evaluated the performance of Monster Beverage's (MNST) international operations for the quarter ending June 2026? Given the extensive global presence of this energy drink maker, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth. …

The Energy Drink Buyout Prize Beverage Giants Are Circling

Quick Read Celsius Holdings (CELH) trades at a ~$7 billion market cap after falling 39% this year, yet commands roughly 20% of the U.S. energy drink market. PepsiCo (PEP) already distributes Celsius and holds an 11% equity stake from a $585 million investment, making …